title: Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
abstract: OBJECTIVE
  To assess the preliminary clinical results of salvage high-dose-rate brachytherapy (HDR-BT) applied in cases of suspected local recurrence or of residual tumour after radiotherapy.
  
  
  METHODS
  The subjects were 11 patients who met the above conditions and underwent salvage HDR-BT between December 2006 and January 2009. The T stage at the initial treatment was T1c in three patients, T2 in three patients and T3 in five patients. Ten patients received HDR-BT ± electron beam radiation therapy and one patient received proton beam irradiation. Follow-up after the completion of salvage HDR-BT lasted 18-41 months (mean 29 months). A dose of 11.0 Gy radiation was delivered twice (22.0Gy in total), separated by a 6-h interval, on the day the applicators were inserted.
  
  
  RESULTS
  Seven of the 11 cases remained in a biochemical non-evidence of disease state. The prostate-specific antigen (PSA) level continuously rose after salvage HDR-BT in three of the four other cases. Hormone administration was initiated in the four cases of PSA recurrence. No G3 or more severe events occurred, and the incidence of G2 was low during this study period.
  
  
  CONCLUSIONS
  Of the 11 cases treated with salvage HDR-BT, PSA levels remained low in seven cases and the incidence of complications was also low. This suggests that salvage HDR-BT is effective as an option for treatment of local prostate cancer recurrence after radiotherapy.
authors.affiliation: Kurashiki Medical School, Kurashiki, Japan.
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Jo
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Fujii
authors.forename: Ryoei
authors.initials: R
authors.lastname: Hara
authors.forename: Teruhiko
authors.initials: T
authors.lastname: Yokoyama
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Miyaji
authors.forename: Eisaku
authors.initials: E
authors.lastname: Yoden
authors.forename: Junichi
authors.initials: J
authors.lastname: Hiratsuka
authors.forename: Atsushi
authors.initials: A
authors.lastname: Nagai
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D016879:Salvage Therapy / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D007496:Iridium Radioisotopes